GERON CORPORATION: A LOT IS RIDING ON IMETELSTAT!
Post# of 119
(Total Views: 581)
Posted On: 06/17/2022 8:15:18 AM
GERON CORPORATION: A LOT IS RIDING ON IMETELSTAT!
$GERN
Geron Corporation (NASDAQ: GERN) is a late-stage clinical biotechnology company developing a first-in-class telomerase inhibitor, imetelstat, intended to treat hematologic malignancies.
A lot is riding on the topline results from the IMerge Phase 3 are expected to be announced in early January 2023.
We take a look at the Company in our article today!
Read on to know more:
https://www.aviseanalytics.com/geron-corporat...metelstat/
$GERN
Geron Corporation (NASDAQ: GERN) is a late-stage clinical biotechnology company developing a first-in-class telomerase inhibitor, imetelstat, intended to treat hematologic malignancies.
A lot is riding on the topline results from the IMerge Phase 3 are expected to be announced in early January 2023.
We take a look at the Company in our article today!
Read on to know more:
https://www.aviseanalytics.com/geron-corporat...metelstat/
(0)
(0)Geron Corporation (GERN) Stock Research Links
Scroll down for more posts ▼